Innovative Pharmacist of the Year
Innovation is the cornerstone of pharmacy. As the profession goes through unprecedented change, we believe it's important to recognise those leading the way.
Nominations for the 2019 Innovative Pharmacist of the Year are now closed. Congratulations to Brad Butt the 2019 Innovative Pharmacist of the Year.
This annual award recognises those in the profession who are redefining pharmacy. Our partner AstraZeneca sponsors this initiative with a $5,000 grant that goes towards to the winner’s professional development.
After identifying a serious gap in the support for men post prostatectomy in 2013, ACT pharmacist Brad Butt established Mens' Health Downunder. Since then, the program has attracted national attention and expanded into areas such as Peyronie’s disease, erectile dysfunction and other urological issues.
Through its new approach to traditional practice, Mens' Health Downunder invites all community pharmacists to rethink their businesses in terms of both better patient care and positive business outcomes.
Find out more about the 2019 Innovative Pharmacist of the Year.
After campaigning for three years, Kirrily Chambers broke new ground when she became Australia’s first pharmacist to become a Credentialled Diabetes Educator (CDE) in 2009. Since then, 220 pharmacists have followed in her footsteps, with hundreds more completing graduate courses in diabetes care and education.
Kayla Lee was announced the winner of the AstraZeneca 2017 UTS Innovative Pharmacist of the Year Award. Lee was inspired to make positive change in her community after the tragedy of losing her father when he took his own life. She saw a gap in the way pharmacists discussed mental health and devised Pharmafriend to fill it. Pharmafriend is a novel program that was implemented at Capital Chemist Wanniassa; it fundamentally changes the way pharmacists interact with patients.
The 2016 award winner was Dr Alison Roberts of the Pharmaceutical Society of Australia. Dr Roberts led the creation of the Health Destination Pharmacy (HDP) program, an evidence-based change initiative that helps pharmacies transition to a professional services business model. The HDP program is based on more than 15 years of work that began during Dr Roberts’s PhD in 2001.
This year’s winner was Swarup Afsar, owner of Pharmacy 777 in Western Australia for his innovative Mental Health Module in Community Pharmacy. Swarup’s innovation was around implementing a counselling service that provides; solution focused psycho-dynamic therapy, cognitive behavioural therapy and hypnotherapy. Mr Afsar said “his innovation is continuing to improve mental health experienced by a whole spectrum of patients – from newly diagnosed diabetics, sleep apnoea sufferer’s to FIFO workers and their partners, and of course people having prescriptions for anti-depressants”.
The 2014 winners were the Queensland Pharmacist Immunisation Pilot (QPIP) implementation team from the Queensland branch of the Pharmaceutical Society of Australia, who worked with 80 pharmacies to deliver a user-pays vaccination program over a period of five months. The project saw pharmacy professionals deliver more than 11,000 vaccinations to members of the public at a fee of $25-$30 each.
The 2013 medal was awarded to Joyce McSwan, a consultant pharmacist, community pharmacist and pharmacy educator who has driven exciting innovations in the field of pain management in Queensland over the last three years.
Read more about McSwan's work and the 2013 Award Ceremony
The 2012 medal was awarded to David Dixon of Goldfields Fullife Pharmacy in Gympie Qld for his introduction of a highly successful Sleep Management Service which produced over $250K revenue in the first year.
- What new concepts or variations on existing ideas have been developed? Have these developments been achieved independently or with help of others?
- Is the concept or variation a fundamental change to common practice or a minor development? Will it lead to other innovations?
- Are the innovations easily integrated into existing practice? Are they cost-effective? Do they come with risk?
- Has the innovation increased revenue, efficiencies, cost savings?
- Can the innovative practice be easily adapted by other pharmacists? Can they be used internationally?